Screener
Perspective Therapeutics CATX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's debt-to-equity?
- Perspective Therapeutics (CATX) reported debt-to-equity of 0× in Q2 2026.
- How has Perspective Therapeutics's debt-to-equity changed year-over-year?
- Perspective Therapeutics's debt-to-equity decreased by 8.3% year-over-year, from 0× to 0×.
- What is the long-term trend for Perspective Therapeutics's debt-to-equity?
- Over 4 years (2020 to 2025), Perspective Therapeutics's debt-to-equity has grown at a -31.6% compound annual growth rate (CAGR), from 0.1× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Perspective Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude